Clincosm LogoSign in Get a demo

advanced solid tumor

Showing NaN - NaN of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, NSCLCs Trial in Houston (Adagrasib, Olaparib)

Not yet recruiting
  • Advanced Solid Tumor
  • Non-small Cell Lung Cancers
  • Houston, Texas
    M D Anderson Cancer Center
Nov 15, 2023

Advanced Solid Tumor Trial in United States (CLN-617, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • Los Angeles, California
  • +5 more
Sep 12, 2023

Advanced Solid Tumor, RAS Mutation, RAF Mutation Trial in Houston, Irving (ABM-168)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Houston, Texas
  • +1 more
Apr 14, 2023

Advanced Solid Tumor Trial in United Kingdom (RP3, Nivolumab)

Recruiting
  • Advanced Solid Tumor
  • RP3
  • Nivolumab
  • Houston, Texas
  • +6 more
Jan 30, 2023

Advanced Solid Tumor Trial in Worldwide (Erdafitinib)

Recruiting
  • Advanced Solid Tumor
  • Tucson, Arizona
  • +199 more
Jan 27, 2023

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Houston (NTX-1088, Pembrolizumab)

Recruiting
  • Cancer
  • +4 more
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jan 24, 2023

Advanced Solid Tumor, Metastatic Breast Cancer Trial in United States (Abraxane)

Active, not recruiting
  • Advanced Solid Tumor
  • Metastatic Breast Cancer
  • Gilbert, Arizona
  • +19 more
Jan 13, 2023

Advanced Solid Tumor, Malignant Solid Tumor Trial in Japan, United States (DS-7300a)

Recruiting
  • Advanced Solid Tumor
  • Malignant Solid Tumor
  • Los Angeles, California
  • +21 more
Jan 5, 2023

Advanced Solid Tumor, BRAF V600 Mutation Trial in United States (ABM-1310, Cobimetinib)

Recruiting
  • Advanced Solid Tumor
  • BRAF V600 Mutation
  • San Francisco, California
  • +3 more
Dec 30, 2022

Cancer, Tumor, Solid, Nonsmall Cell Lung Cancer Trial in United States (HMBD-002, Pembrolizumab)

Recruiting
  • Cancer
  • +6 more
  • Duarte, California
  • +6 more
Dec 26, 2022

Advanced Solid Tumor, Metastatic Solid Tumor, Urothelial Carcinoma Trial in United States (Lurbinectedin)

Recruiting
  • Advanced Solid Tumor
  • +4 more
  • Stanford, California
  • +15 more
Dec 21, 2022

Advanced Solid Tumor Trial in United States (GS-1811, Zimberelimab)

Recruiting
  • Advanced Solid Tumor
  • La Jolla, California
  • +8 more
Dec 8, 2022

Advanced Solid Tumor, MSI-H/dMMR Tumors, Cutaneous Squamous Cell Carcinoma Trial in Worldwide (INCB099280)

Recruiting
  • Advanced Solid Tumor
  • +11 more
  • Boston, Massachusetts
  • +30 more
Dec 1, 2022

Advanced Solid Tumor Trial in Los Angeles (EP0031)

Recruiting
  • Advanced Solid Tumor
  • Los Angeles, California
  • +3 more
Dec 1, 2022

Advanced Solid Tumor, Urinary Bladder Tumor, Pancreatic Tumors Trial in Worldwide (BT8009, Nivolumab)

Recruiting
  • Advanced Solid Tumor
  • +4 more
  • Denver, Colorado
  • +20 more
Nov 22, 2022

Advanced Solid Tumor Trial in Worldwide (RP-3500, Talazoparib, Gemcitabine Injection [Gemzar])

Recruiting
  • Advanced Solid Tumor
  • Chicago, Illinois
  • +12 more
Nov 18, 2022

Advanced Solid Tumor Trial in Korea, Republic of, United States (hSTC810)

Recruiting
  • Advanced Solid Tumor
  • hSTC810
  • New Haven, Connecticut
  • +4 more
Nov 16, 2022

KRAS Mutation-Related Tumors, Metastatic Solid Tumor, Advanced Solid Tumor Trial in United States (TPX-0005, Trametinib)

Active, not recruiting
  • KRAS Mutation-Related Tumors
  • +2 more
  • Los Angeles, California
  • +5 more
Nov 7, 2022

Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • PY159 Single agent dose level 1
  • +17 more
  • San Francisco, California
  • +11 more
Nov 3, 2022

Advanced Solid Tumor, Cutaneous T-cell Lymphoma (CTCL) Trial in United States (SIM1811-03)

Recruiting
  • Advanced Solid Tumor
  • Cutaneous T-cell Lymphoma (CTCL)
  • Detroit, Michigan
  • +5 more
Oct 6, 2022

Advanced Solid Tumor Trial in United States (Nemvaleukin alfa, Pembrolizumab)

Recruiting
  • Advanced Solid Tumor
  • Nemvaleukin alfa
  • Pembrolizumab
  • Grand Rapids, Michigan
  • +3 more
Aug 30, 2022

Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma Trial in Korea, Republic of, Singapore, United

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Duarte, California
  • +22 more
Aug 17, 2022

Advanced Solid Tumor, Advanced Malignant Tumor, Metastatic Cancer Trial in United States (PC14586)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
  • +10 more
Aug 12, 2022

Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)

Recruiting
  • Advanced Solid Tumor
  • +18 more
  • PT199
  • Anti-PD-1 monoclonal antibody
  • Huntersville, North Carolina
  • +2 more
Aug 10, 2022